Pharmafile Logo

BI

- PMLiVE

Boehringer bolts on another immuno-oncology company

Acquires ViraTherapeutics in a €210m takeover deal

- PMLiVE

Boehringer abandons PDE-targeted Alzheimer’s drug

But will keep testing the candidate in schizophrenia

- PMLiVE

Boehringer bolsters NASH pipeline with $201m Dicerna deal

Will investigate a “new therapeutic approach” to target liver functionality

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links